Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.
- Status
- COMPLETED
- Phase
- NA
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c
- Status
- UNKNOWN
- Phase
- N/A
18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis
- Status
- UNKNOWN
- Phase
- NA
Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy
- Status
- COMPLETED
- Phase
- N/A
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma
- Status
- COMPLETED
- Phase
- NA
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
- Status
- COMPLETED
- Phase
- NA
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2